(iii) Any information contained in the re-petition which is inconsistent with the original petition must be identified and a description of the reason for the inconsistency must accompany the re-petition.
      (iv) In cases where the Administrator does not object to the petition based on the criteria listed in paragraph (c)(4)(i) of this section, the Administrator will issue a non-objection notice.
      (v) To pass the approved used class II controlled substances through U.S. Customs, the non-objection notice issued by EPA must accompany the shipment through U.S. Customs.
      (vi) If for some reason, following EPA's issuance of a non-objection notice, new information is brought to EPA's attention which shows that the non-objection notice was issued based on false information, then EPA has the right to:
      (A) Revoke the non-objection notice;
      (B) Pursue all means to ensure that the class II controlled substance is not imported into the U.S.; and
      (C) Take appropriate enforcement actions.

       (vii) A person receiving the non-objection notice is permitted to import the individual shipment only within one year of the date stamped on the non-objection notice.
      (viii) A person receiving a non-objection notice from the Administrator for a petition to import used class II controlled substances must maintain the following records:
      (A) A copy of the petition;
      (B) The EPA non-objection notice;
      (C) The bill of lading for the import; and
      (D) The U.S. Customs entry number.
      (5) Recordkeeping for transhipments -- Importers. Any person who tranships a class II controlled substance must maintain records that indicate:
      (i) That the class II controlled substance shipment originated in a foreign country;
      (ii) That the class II controlled substance shipment is destined for another foreign country; and
      (iii) That the class II controlled substance shipment will not enter interstate commerce within the U.S.
      (6) Certification of Intent to Import for Destruction. For each individual shipment of a class II controlled substance imported with the intent to destroy that substance, an importer must submit electronically to the Administrator, at least 30 working days before the shipment is to leave the foreign port of export, the following information:
      (i) Name, commodity code, and quantity in kilograms of each controlled substance to be imported,
      (ii) Name and address of the importer, the importer ID number, and the contact person's name, email address, and phone number;
      (iii) Name and address of any intermediary who aggregates controlled substances imported for destruction, and the contact person's name, email address, and phone number;
      (iv) The U.S. port of entry for the import, the expected date of shipment and the vessel transporting the material. If at the time of submitting the certification of intent to import for destruction the importer does not know the U.S. port of entry, the expected date of shipment and the vessel transporting the material, and the importer receives a non-objection notice for the individual shipment in the petition, the importer is required to notify the Administrator of this information prior to the entry of the individual shipment into the United States;
      (v) Name, address, contact person, email address, and phone number of the responsible party at the destruction facility;
      (vi) The export license, application for an export license, or official communication acknowledging the export from the appropriate government agency in the country of export and, if recovered in another country, the export license or official communication from the appropriate government agency in that country, and quantity authorized for export in kilograms on the export license, and an English translation of these documents; and
      (vii) A certification of accuracy of the information submitted in the certification.
      (7) For each individual shipment of a class II controlled substance imported with the intent to destroy that substance, an importer must submit to the Administrator a copy of the destruction verification within 30 days after destruction of the controlled substance(s).
      (8) (i) Starting on the first working day following receipt by the Administrator of a certification of intent to import a class II controlled substance for destruction, the Administrator will initiate a review of the information submitted under paragraph (c)(6) of this section and take action within 30 working days to issue either an objection-notice or a non-objection notice for the individual shipment to the person who submitted the certification of intent to import the class II controlled substance for destruction.
      (ii) The Administrator may issue an objection notice if the petition lacks or appears to lack any of the information required under paragraph (c)(6) or for the reasons listed in §82.24(c)(4)(i)(B)-(E).
      (iii) In cases where the Administrator does not object to the petition, the Administrator will issue a non-objection notice.
      (iv) To pass the approved class II controlled substances through U.S. Customs, the non-objection notice issued by EPA must accompany the shipment through U.S. Customs.
      (v) If for some reason, following EPA's issuance of a non-objection notice, new information is brought to EPA's attention which shows that the non-objection notice was issued based on false information, then EPA has the right to:
      (A) Revoke the non-objection notice;
      (B) Pursue all means to ensure that the class II controlled substance is not imported into the United States; and
      (C) Take appropriate enforcement actions.
      (9) A person receiving the non-objection notice is permitted to import the individual shipment only within one year of the date stamped on the non-objection notice.
      (10) A person receiving a non-objection notice from the Administrator for a certification of intent to import class II controlled substances for destruction must maintain the following records:
      (i) A copy of the certificate of intent to import for destruction;
      (ii) The EPA non-objection notice;
      (iii) A copy of the export license, export license application, or official communication from the appropriate government agency in the country of export;
      (iv) U.S. Customs entry documents for the import that must include one of the commodity codes from Appendix K to this subpart;
      (v) The date, amount, and type of controlled substance sent for destruction, per shipment;
      (vi) An invoice from the destruction facility verifying the shipment was received;
	(vii) A copy of the destruction verification from the destruction facility; and
      (viii) An English translation of the document in paragraph (iii).
      (11) A person identified in §82.24(c)(6)(iii) as aggregating a controlled substance prior to destruction must:
      (i) Maintain transactional records that include the name and address of the entity from whom they received the controlled substance imported for destruction;
      (ii) Maintain transactional records that include the name and address of the entity to whom they sent the controlled substance imported for destruction;
      (iii) Maintain records that include the date and quantity of the imported controlled substance received for destruction;
      (iv) Maintain records that include the date and quantity of the imported controlled substance sent for destruction; and
      (v) If the person is the final aggregator of such a controlled substance before the material is destroyed, maintain a copy of the destruction verification.

	(d) Exporters Persons ("exporters") who export class II controlled substances during a control period must comply with the following reporting requirements:
      (1) Reporting -- Exporters. For any exports of class II controlled substances not reported under paragraph (b)(2) of this section (reporting for producers of class II controlled substances), each exporter who exported a class II controlled substance must submit to the Administrator the following information within 30 days after the end of each quarter in which the unreported exports left the United States:
       (i) The names and addresses of the exporter and the recipient of the exports;
      (ii) The exporter's Employer Identification Number;
      (iii) The type and quantity  of each class II controlled substance exported, including the  quantity of controlled substance that is used, recycled or reclaimed;
      (iv) The date on which, and the port from which, the class II controlled substances were exported from the U.S. or its territories;
      (v) The country to which the class II controlled substances were exported;
      (vi) The quantity (in kilograms) exported to each Article 5 country;
      (vii) The commodity code for the class II controlled substances shipped, which must be one of those listed in Appendix K to this subpart;
      (viii) For persons reporting transformation or destruction, the invoice or sales agreement containing language similar to the transformation verifications that the purchaser or recipient of imported class II controlled substances intends to transform those substances, or destruction verifications showing that the purchaser or recipient intends to destroy the class II controlled substances (as provided in paragraph (e) of this section).

	(3) Reporting Article 5 allowances -- Exporters. In addition to the information required in paragraph (d)(1) of this section, any exporter using Article 5 allowances must also provide the following to the Administrator:
      (i) The Employer Identification Number of the shipper or their agent; and
      (ii) The exporting vessel on which the class II controlled substances were shipped.
      (4) Reporting used class II controlled substances -- Exporters. Any exporter of used class II controlled substances must indicate on the bill of lading or invoice that the class II controlled substance is used, as defined in §82.3.
      (e) Transformation and destruction. Any person who transforms or destroys class II controlled substances must comply with the following recordkeeping and reporting requirements:
      (1) Recordkeeping -- Transformation and destruction. Any person who transforms or destroys class II controlled substances produced or imported by another person must maintain the following:
      (i) Copies of the invoices or receipts documenting the sale or transfer of the class II controlled substances to the person;
      (ii) Records identifying the producer or importer of the class II controlled substances received by the person;
      (iii) Dated records of inventories of class II controlled substances at each plant on the first day of each quarter;
      (iv) Dated records of the quantity (in kilograms) of each class II controlled substance transformed or destroyed;
      (v) In the case where class II controlled substances were purchased or transferred for transformation purposes, a copy of the person's transformation verification as provided under paragraph (e)(3)of this section.
      (vi) Dated records of the names, commercial use, and quantities (in kilograms) of the resulting chemical(s) when the class II controlled substances are transformed; and
      (vii) Dated records of shipments to purchasers of the resulting chemical(s) when the class II controlled substances are transformed.
      (viii) In the case where class II controlled substances were purchased or transferred for destruction purposes, a copy of the person's destruction verification, as provided under paragraph (e)(5) of this section.
      (2) Reporting -- Transformation and destruction. Any person who transforms or destroys class II controlled substances and who has submitted a transformation verification ((paragraph (e)(3) of this section) or a destruction verification (paragraph (e)(5) of this section) to the producer or importer of the class II controlled substances, must report the following:
      (i) The names and quantities (in kilograms) of the class II controlled substances transformed for each control period within 45 days of the end of such control period; and
      (ii) The names and quantities (in kilograms) of the class II controlled substances destroyed for each control period within 45 days of the end of such control period.
      (3) Reporting -- Transformation. Any person who purchases class II controlled substances for purposes of transformation must provide the producer or importer with a transformation verification that the class II controlled substances are to be used in processes that result in their transformation.
      (i) The transformation verification shall include the following:
      (A) Identity and address of the person intending to transform the class II controlled substances;
      (B) The quantity (in kilograms) of class II controlled substances intended for transformation;
      (C) Identity of shipments by purchase order number(s), purchaser account number(s), by location(s), or other means of identification;
      (D) Period of time over which the person intends to transform the class II controlled substances; and
      (E) Signature of the verifying person.
      (4) Reporting -- Destruction. Any person who destroys class II controlled substances shall provide EPA with a one-time report containing the following information:
      (i) The destruction unit's destruction efficiency;
      (ii) The methods used to record the volume destroyed;
      (iii) The methods used to determine destruction efficiency;
      (iv) The name of other relevant federal or state regulations that may apply to the destruction process;
      (v) Any changes to the information in paragraphs (e)(4)(i), (ii), and (iii) of this section must be reflected in a revision to be submitted to EPA within 60 days of the change(s).
      (5) Reporting -- Destruction. Any person who purchases or receives and subsequently destroys class II controlled substances that were originally produced without expending allowances shall provide the producer or importer from whom it purchased or received the class II controlled substances with a verification that the class II controlled substances will be used in processes that result in their destruction.
      (i) The destruction verification shall include the following:
      (A) Identity and address of the person intending to destroy class II controlled substances;
      (B) Indication of whether those class II controlled substances will be completely destroyed, as defined in §82.3, or less than completely destroyed, in which case the destruction efficiency at which such substances will be destroyed must be included;
      (C) Period of time over which the person intends to destroy class II controlled substances; and
      (D) Signature of the verifying person.
      (f) Heels-Recordkeeping and reporting. Any person who brings into the U.S. a rail car, tank truck, or ISO tank containing a heel, as defined in §82.3, of class II controlled substances, must take the following actions:
      (1) Indicate on the bill of lading or invoice that the class II controlled substance in the container is a heel.
      (2) Report within 30 days of the end of the control period the quantity (in kilograms) brought into the U.S. and certify:
      (i) That the residual quantity (in kilograms) in each shipment is no more than 10 percent of the volume of the container;
      (ii) That the residual quantity (in kilograms) in each shipment will either:
      (A) Remain in the container and be included in a future shipment;
      (B) Be recovered and transformed;
      (C) Be recovered and destroyed; or
      (D) Be recovered for a non-emissive use.
      (3) Report on the final disposition of each shipment within 30 days of the end of the control period.

Appendix K to Subpart A of Part 82 -- Commodity Codes from the Harmonized Tariff Schedule for Controlled Substances and Used Controlled Substances
                     Description of commodity or chemical
                Commodity code from harmonized tariff schedule
Class II:

HCFC-22 (Chlorodifluoromethane)
                                                                   2903.71.0000
HCFC-123 (Dichlorotrifluoroethane)
                                                                   2903.72.0020
HCFC-124 (Monochlorotetrafluoroethane)
                                                                   2903.79.1000
HCFC-141b (Dichlorofluoroethane)
                                                                   2903.73.0000
HCFC-142b (Chlorodifluoroethane)
                                                                   2903.74.0000
HCFC-225ca, HCFC-225cb (Dichloropentafluoropropanes)
                                                                   2903.75.0000
HCFC-21, HCFC-31, HCFC-133, and other HCFCs
                                                                   2903.79.9070
HCFC Mixtures (R-401A, R-402A, etc.)
                                                                   3824.74.0000
Class I:

CFC-11 (Trichlorofluoromethane)
                                                                   2903.77.0010
CFC-12 (Dichlorodifluoromethane)
                                                                   2903.77.0050
CFC-113 (Trichlorotrifluoroethane)
                                                                   2903.77.0020
CFC-114 (Dichlorotetrafluoroethane)
                                                                   2903.77.0030
CFC-115 (Monochloropentafluoroethane)
                                                                   2903.77.0040
    CFC-13, CFC-111, CFC-112, CFC-211, CFC-212, CFC-213, CFC-214, CFC-215, CFC-216, CFC-217, and other CFCs
                                                                   2903.77.0080
CFC Mixtures (R-500, R-502, etc.)
                                                                   3824.71.0100
Carbon Tetrachloride
                                                                   2903.14.0000
Halon 1301 (Bromotrifluoromethane)
                                                                   2903.76.0010
Halon, other
                                                                   2903.76.0050
Methyl Bromide
                                                                   2903.39.1520
Methyl Chloroform
                                                                   2903.19.6010

§82.62   Definitions.
For purposes of this subpart:
Chlorofluorocarbon means any substance listed as Class I group I or Class I group III in 40 CFR part 82, appendix A to subpart A.
Class II Substance means any substance designated as class II in 40 CFR part 82, appendix B to subpart A.
Commercial, when used to describe the purchaser of a product, means a person that uses the product in the purchaser's business or sells it to another person and has one of the following identification numbers:
      (1) A federal employer identification number;
      (2) A state sales tax exemption number;
      (3) A local business license number; or
      (4) A government contract number.
Consumer, when used to describe a person taking action with regard to a product, means the ultimate purchaser, recipient or user of a product.
Distributor, when used to describe a person taking action with regard to a product means:
      (1) The seller of a product to a consumer or another distributor; or
      (2) A person who sells or distributes that product in interstate commerce for export from the United States.
Foam Insulation Product, when used to describe a product containing or consisting of plastic foam, means a product containing or consisting of the following types of foam:
      (1) Closed cell rigid polyurethane foam;
      (2) Closed cell rigid polystyrene boardstock foam;
      (3) Closed cell rigid phenolic foam; and
      (4) Closed cell rigid polyethylene foam when such foam is suitable in shape, thickness and design to be used as a product that provides thermal insulation around pipes used in heating, plumbing, refrigeration, or industrial process systems.
Hydrochlorofluorocarbon means any substance listed as class II in 40 CFR part 82, appendix B to subpart A.
Initial Inventory means that the original product has completed all of its manufacturing processes and is ready for sale by the manufacturer. Products in initial inventory may be subsequently incorporated into another product by a different manufacturer after purchase. To continue selling products after the effective date of the provisions, the manufacturer or distributor must be able to show, upon request by EPA, that the product was in fact manufactured, and thus placed into initial inventory prior to the effective date. Shipping forms, lot numbers, manufacturer date stamps or codes, invoices, or the like are normally kept records that could be maintained from the time the product was put into initial inventory and may be used to demonstrate when a product was placed in initial inventory.
Polyurethane Foam System means an item consisting of two transfer pumps that deliver ingredients (polyisocyanate or isocyanate from one side and a mixture including the blowing agent, catalysts, flame retardants, and/or stabilizers from the other side) to a metering/mixing device which allows the components to be delivered in the appropriate proportions.

Product means an item or category of items manufactured from raw or recycled materials which is used to perform a function or task.
Release means to emit into the environment during the manufacture, use, storage or disposal of a product.
Space Vehicles means a man-made device, either manned or unmanned, designed for operation beyond earth's atmosphere. This definition includes integral equipment such as models, mock-ups, prototypes, molds, jigs, tooling, hardware jackets, and test coupons. Also included is auxiliary equipment associated with test, transport, and storage, which through contamination can compromise the space vehicle performance.
§82.64 Prohibitions
      (a) Effective February 16, 1993, no person may sell or distribute, or offer to sell or distribute, in interstate commerce any of the products identified as being nonessential in §82.66(a).
      (b) Effective February 16, 1993, no person may sell or distribute, or offer to sell or distribute, in interstate commerce any of the products specified in §82.66(b) to a person who does not provide proof of being a commercial purchaser, as defined under §82.62.
      (c) Effective January 17, 1994, no person may sell or distribute, or offer to sell or distribute, in interstate commerce any of the products identified as being nonessential in §82.66(c) or §82.66(d) except as permitted under §82.65(g).
      (d) Except as permitted under §82.65, effective January 1, 1994, no person may sell or distribute, or offer for sale or distribution, in interstate commerce any product identified as being nonessential in §82.70(a) or §82.70(c).
      (e) Except as permitted under §82.65, effective January 1, 1994, no person may sell or distribute, or offer to sell or distribute, in interstate commerce any of the products specified in §82.70(b) to a person who does not provide proof of being a commercial purchaser, as defined under §82.62.
      (f) Except as permitted under §82.65(d), effective January 1, 1996, no person may sell or distribute, or offer for sale or distribution, in interstate commerce any product identified as being nonessential in §82.70(c)(ii).
      (g) It is a violation of this subpart to sell or distribute, or offer for sale or distribution, products effected by the provisions of §82.68 if the seller knew or should have known that the purchaser was purchasing the product for a prohibited application.
	(h) No person may sell or distribute, or offer to sell or distribute, in interstate commerce any of the products identified as being nonessential in §82.66(f).

§82.66 Nonessential Class I products and exceptions.
      The following products which release a Class I substance (as defined in 40 CFR part 82, appendix A to subpart A) are identified as being nonessential, and subject to the prohibitions specified under § 82.64 -
      (a) Any plastic party streamer or noise horn which is propelled by a chlorofluorocarbon, including but not limited to -
      (1) String confetti;
      (2) Marine safety horns;
      (3) Sporting event horns;
      (4) Personal safety horns;
      (5) Wall-mounted alarms used in factories or other work areas; and
      (6) Intruder alarms used in homes or cars.
      (b) Any cleaning fluid for electronic and photographic equipment which contains a chlorofluorocarbon:
      (1) Including but not limited to liquid packaging, solvent wipes, solvent sprays, and gas sprays; and
      (2) Except for those sold or distributed to a commercial purchaser.
      (c) Any plastic foam product which is manufactured with or contains a Class I substance; but which contains no other Class I substances and where this product is used to provide thermal protection to external tanks for space vehicles;
      (d) Any aerosol product or other pressurized dispenser, other than those banned in §82.64(a) or §82.64(b), which contains a chlorofluorocarbon,
      (1) Including but not limited to household, industrial, automotive and pesticide uses,
      (2) Except -
      (i) Medical devices listed in 21 CFR 2.125(e);
      (ii) Lubricants, coatings or cleaning fluids for electrical or electronic equipment, which contain CFC-11, CFC-12, or CFC-113 for solvent purposes, but which contain no other CFCs;
      (iii) Lubricants, coatings or cleaning fluids used for aircraft maintenance, which contain CFC-11 or CFC-113 as a solvent, but which contain no other CFCs;
      (iv) Mold release agents used in the production of plastic and elastomeric materials, which contain CFC-11 or CFC-113 as a solvent, but which contain no other CFCs, and/or mold release agents that contain CFC-12 as a propellant, but which contain no other CFCs;
      (v) Spinnerette lubricant/cleaning sprays used in the production of synthetic fibers, which contain CFC-114 as a solvent, but which contain no other CFCs, and/or spinnerette lubricant/cleaning sprays which contain CFC-12 as a propellant, but which contain no other CFCs;
      (vi) Document preservation sprays which contain CFC-113 as a solvent, but which contain no other CFCs, and/or document preservation sprays which contain CFC-12 as a propellant, but which contain no other CFCs, and which are used solely on thick books, books with coated or dense paper and tightly bound documents;
      (e) Any air-conditioning or refrigeration appliance as defined in CAA 601(l) that contains a Class I substance used as a refrigerant, and
      (f) Any polyurethane foam system that contains any CFC

§82.104 Definitions.
      (a) Class I substance means any substance designated as class I in 40 CFR part 82, appendix A to subpart A, including chlorofluorocarbons, halons, carbon tetrachloride and methyl chloroform and any other substance so designated by the Agency at a later date.
      (b) Class II substance means any substance designated as class II in 40 CFR part 82, appendix A to subpart A, including hydrochlorofluorocarbons and any other substance so designated by the Agency at a later date.

       (c) Completely destroy means to cause the destruction of a controlled substance by one of the destruction processes approved by the Parties and listed in §82.3 of subpart A at a demonstrable destruction efficiency of 98 percent or more or a greater destruction efficiency if required under other applicable federal regulations.
      (d) Consumer means a commercial or non-commercial purchaser of a product or container that has been introduced into interstate commerce.
      (e) Container means the immediate vessel in which a controlled substance is stored or transported.
      (f) Container containing means a container that physically holds a controlled substance within its structure that is intended to be transferred to another container, vessel or piece of equipment in order to realize its intended use.
      (g) Controlled substance means a class I or class II ozone-depleting substance.

       (h) Destruction means the expiration of a controlled substance to the destruction efficiency actually achieved, unless considered completely destroyed as defined in this section. Such destruction might result in a commercially useful end product but such usefulness would be secondary to the act of destruction. Destruction must be achieved using one of the controlled processes approved by the Parties and listed in the definition of destruction in §82.3 of subpart A.

      (i) Distributor means a person to whom a product is delivered or sold for purposes of subsequent resale, delivery or export.
      (j) Export means the transport of virgin, used, or recycled class I or class II substances or products manufactured or containing class I or class II substances from inside the United States or its territories to persons outside the United States or its territories, excluding United States military bases and ships for on-board use.
      (k) Exporter means the person who contracts to sell class I or class II substances or products manufactured with or containing class I or class II substances for export or transfers such substances or products to his affiliate in another country.
      (l) Import means to land on, bring into, or introduce into, or attempt to land on, bring into, or introduce into any place subject to the jurisdiction of the United States whether or not such landing, bringing, or introduction constitutes an importation within the meaning of the customs laws of the United States, with the exception of temporary off-loading of products manufactured with or containers containing class I or class II substances from a ship are used for servicing of that ship.
      (m) Importer means any person who imports a controlled substance, a product containing a controlled substance, a product manufactured with a controlled substance, or any other chemical substance (including a chemical substance shipped as part of a mixture or article), into the United States. "Importer" includes the person primarily liable for the payment of any duties on the merchandise or an authorized agent acting on his or her behalf. The term also includes, as appropriate:
      (1) The consignee;
      (2) The importer of record;
      (3) The actual owner if an actual owner's declaration and superseding bond has been filed; or
      (4) The transferee, if the right to draw merchandise in a bonded warehouse has been transferred.
      (n) Interstate commerce means the distribution or transportation of any product between one state, territory, possession or the District of Columbia, and another state, territory, possession or the District of Columbia, or the sale, use or manufacture of any product in more than one state, territory, possession or District of Columbia. The entry points for which a product is introduced into interstate commerce are the release of a product from the facility in which the product was manufactured, the entry into a warehouse from which the domestic manufacturer releases the product for sale or distribution, and at the site of United States Customs clearance.
      (o) Manufactured with a controlled substance means that the manufacturer of the product itself used a controlled substance directly in the product's manufacturing, but the product itself does not contain more than trace quantities of the controlled substance at the point of introduction into interstate commerce. The following situations are excluded from the meaning of the phrase "manufactured with" a controlled substance:
      (1) Where a product has not had physical contact with the controlled substance;
      (2) Where the manufacturing equipment or the product has had physical contact with a controlled substance in an intermittent manner, not as a routine part of the direct manufacturing process;
      (3) Where the controlled substance has been transformed, except for trace quantities; or
      (4) Where the controlled substance has been completely destroyed.
      (p) Potentially available means that adequate information exists to make a determination that the substitute is technologically feasible, environmentally acceptable and economically viable.
      (q) Principal display panel (PDP) means the entire portion of the surface of a product, container or its outer packaging that is most likely to be displayed, shown, presented, or examined under customary conditions of retail sale. The area of the PDP is not limited to the portion of the surface covered with existing labeling; rather it includes the entire surface, excluding flanges, shoulders, handles, or necks.
      (r) Product means an item or category of items manufactured from raw or recycled materials, or other products, which is used to perform a function or task.
      (s) Product containing means a product including, but not limited to, containers, vessels, or pieces of equipment, that physically holds a controlled substance at the point of sale to the ultimate consumer which remains within the product.
      (t) Promotional printed material means any informational or advertising material (including, but not limited to, written advertisements, brochures, circulars, desk references and fact sheets) that is prepared by the manufacturer for display or promotion concerning a product or container, and that does not accompany the product to the consumer.
      (u) Retailer means a person to whom a product is delivered or sold, if such delivery or sale is for purposes of sale or distribution in commerce to consumers who buy such product for purposes other than resale.
      (v) Spare parts means those parts that are supplied by a manufacturer to another manufacturer, distributor, or retailer, for purposes of replacing similar parts with such parts in the repair of a product.
      (w) Supplemental printed material means any informational material (including, but not limited to, package inserts, fact sheets, invoices, material safety data sheets, procurement and specification sheets, or other material) which accompanies a product or container to the consumer at the time of purchase.
      (x) Transform means to use and entirely consume a class I or class II substance, except for trace quantities, by changing it into one or more substances not subject to this subpart in the manufacturing process of a product or chemical.
      (y) Type size means the actual height of the printed image of each capital letter as it appears on a label.
      (z) Ultimate consumer means the first commercial or non-commercial purchaser of a container or product that is not intended for re-introduction into interstate commerce as a final product or as part of another product.
      (aa) Warning label means the warning statement required by section 611 of the Act. The term warning statement shall be synonymous with warning label for purposes of this subpart.
      (bb) Waste means, for purposes of this subpart, items or substances that are discarded with the intent that such items or substances will serve no further useful purpose.
      (cc) Wholesaler means a person to whom a product is delivered or sold, if such delivery or sale is for purposes of sale or distribution to retailers who buy such product for purposes of resale.
§82.106   Warning statement requirements.

       (a) Required warning statements. (1) Unless otherwise exempted by this subpart, each container or product identified in §82.102 (a) or (b) shall bear the following warning statement, meeting the requirements of this subpart for placement and form:
      WARNING: Contains [or Manufactured with, if applicable] [insert name of substance], a substance which harms public health and environment by destroying ozone in the upper atmosphere.
      (2) Each container of fire suppression agent containing HCFC-123 produced or imported on or after January 1, 2020 shall bear the following warning statement, meeting the requirements of this subpart for placement and form:
      WARNING: Contains [insert name of substance], a substance which harms public health and environment by destroying ozone in the upper atmosphere. Use Only for Recharge of Equipment Manufactured before January 1, 2020.
      (3) Each container of fire suppression agent containing reclaimed HCFC-123 or HCFC-123 that was imported prior to January 1, 2020, shall bear the following warning statement, meeting the requirements of this subpart for placement and form:
      WARNING: Contains [insert name of substance], a substance which harms public health and environment by destroying ozone in the upper atmosphere. For use in any equipment.
       (b) Exemptions from warning label requirement. The following products need not bear a warning label:
      (1) Products containing trace quantities of a controlled substance remaining as a residue or impurity due to a chemical reaction, and where the controlled substance serves no useful purpose in or for the product itself. However, if such product was manufactured using the controlled substance, the product is required to be labeled as a "product manufactured with" the controlled substance, unless otherwise exempted;
      (2) Containers containing a controlled substance in which trace quantities of that controlled substance remain as a residue or impurity;
      (3) Waste containing controlled substances or blends of controlled substances bound for discard;
      (4) Products manufactured using methyl chloroform or CFC-113 by persons who can demonstrate and certify a 95% reduction in overall usage from their 1990 calendar year usage of methyl chloroform or CFC-113 as solvents during a twelve (12) month period ending within sixty (60) days of such certification or during the most recently completed calendar year. In calculating such reduction, persons may subtract from quantities used those quantities for which they possess accessible data that establishes the amount of methyl chloroform or CFC-113 transformed. Such subtraction must be performed for both the applicable twelve month period and the 1990 calendar year. If at any time future usage exceeds the 95% reduction, all products manufactured with methyl chloroform or CFC-113 as solvents by that person must be labeled immediately. No person may qualify for this exemption after May 15, 1994;
      (5) Products intended only for export outside of the United States shall not be considered "products introduced into interstate commerce" provided such products are clearly designated as intended for export only;
      (6) Products that are otherwise not subject to the requirements of this subpart that are being repaired, using a process that uses a controlled substance.
      (7) Products, processes, or substitute chemicals undergoing research and development, by which a controlled substance is used. Such products must be labeled when they are introduced into interstate commerce.
      (c) Interference with other required labeling information. The warning statement shall not interfere with, detract from, or mar any labeling information required on the labeling by federal or state law.

§82.270 Prohibitions.
      (a) Effective April 6, 1998 no person may newly manufacture any halon blend. Halon blends manufactured solely for the purpose of aviation fire protection are not subject to this prohibition, provided that:
      (1) The manufacturer or its designee is capable of recycling the blend to the relevant industry standards for the chemical purity of each individual halon;
      (2) The manufacturer includes in all sales contracts for blends produced by it on or after April 6, 1998 the provision that the blend must be returned to it or its designee for recycling; and
      (3) The manufacturer or its designee in fact recycles blends produced by the manufacturer on or after April 6, 1998 and returned to it for recycling to the relevant industry standards for the chemical purity of each individual halon.
      (b) Effective April 6, 1998, no person testing, maintaining, servicing, repairing, or disposing of halon-containing equipment or using such equipment for technician training may knowingly vent or otherwise release into the environment any halons used in such equipment.
      (1) De minimis releases associated with good faith attempts to recycle or recover halon are not subject to this prohibition.
      (2) Release of residual halon contained in fully discharged total flooding fire extinguishing systems would be considered a de minimis release associated with good faith attempts to recycle or recover halon.
      (3) Release of halons during testing of fire extinguishing systems is not subject to this prohibition if the following four conditions are met:
      (i) Systems or equipment employing suitable alternative fire extinguishing agents are not available;
      (ii) System or equipment testing requiring release of extinguishing agent is essential to demonstrate system or equipment functionality;
      (iii) Failure of the system or equipment would pose great risk to human safety or the environment; and (iv) A simulant agent cannot be used in place of the halon during system or equipment testing for technical reasons.
      (4) Releases of halons associated with research and development of halon alternatives, and releases of halons necessary during analytical determination of halon purity using established laboratory practices are exempt from this prohibition.
      (5) This prohibition does not apply to qualification and development testing during the design and development process of halon-containing systems or equipment when such tests are essential to demonstrate system or equipment functionality and when a suitable simulant agent can not be used in place of the halon for technical reasons.
      (6) This prohibition does not apply to the emergency release of halons for the legitimate purpose of fire extinguishing, explosion inertion, or other emergency applications for which the equipment or systems were designed.
      (c) Effective April 6, 1998, organizations that employ technicians who test, maintain, service, repair or dispose of halon-containing equipment shall take appropriate steps to ensure that technicians hired on or before April 6, 1998 will be trained regarding halon emissions reduction by September 1, 1998. Technicians hired after April 6, 1998 shall be trained regarding halon emissions reduction within 30 days of hiring, or by September 1, 1998, whichever is later.
      (d) Effective April 6, 1998, no person shall dispose of halon-containing equipment except by sending it for halon recovery to a manufacturer operating in accordance with NFPA 10 and NFPA 12A standards, a fire equipment dealer operating in accordance with NFPA 10 and NFPA 12A standards or a recycler operating in accordance with NFPA 10 and NFPA 12A standards. This provision does not apply to ancillary system devices such as electrical detection control components which are not necessary to the safe and secure containment of the halon within the equipment, to fully discharged total flooding systems, or to equipment containing only de minimis quantities of halons.

       (e) Effective April 6, 1998, no person shall dispose of halon except by sending it for recycling to a recycler operating in accordance with NFPA 10 and NFPA 12A standards, or by arranging for its destruction using one of the controlled processes approved by the Parties and listed in the definition of destruction in §82.3 of subpart A of this part.

      (f) Effective April 6, 1998, no owner of halon-containing equipment shall allow halon release to occur as a result of failure to maintain such equipment.


<!DOCTYPE HTML PUBLIC "-//-//W3C//DTD HTML 3.2//EN">

<META name="generator" content=" ">
<META name="creation-date" content="20/12/2010 11:14:40 ">
<TITLE> </TITLE>

UNITED STATES ENVIRONMENTAL PROTECTION AGENCY
WASHINGTON, D.C. 20460
OFFICE OF CHEMICAL SAFETY
AND POLLUTION PREVENTION
MEMORANDUM
December 1, 2010
SUBJECT: Cyprodinil Human Health Risk Assessment for Amended Use and Amended
Tolerance Petition for Pome Fruit
PC Code: 288202
DP Barcode: D383614
Decision No.:  428920
Registration No.: 100-828 and 100-1317
Petition No.: 0F7696
Regulatory Action: Amended Section 3
Risk Assessment Type:  Single Chemical Aggregate
Case No.:  7025
TXR No.: NA
CAS No.: 121552-61-2
MRID No.:  NA
40 CFR:  180.532
FROM:
Becky Daiss, Biologist
Bonnie Cropp-Kohlligian, Environmental Scientist
Thurston Morton, Chemist
Risk Assessment Branch 4
Health Effects Division (7509P)
THROUGH:  Susan V. Hummel, Branch Senior Scientist
Risk Assessment Branch 4, HED (7509P)
TO:
Lisa Jones, Risk Manager Reviewer
Fungicide Branch
Registration Division (7505P)
This document provides Health Effects Division’s (HED’s) risk assessment of the
amended Section 3 registration for use of cyprodinil on pome fruit.  Supporting documents are
listed below.
Residue Chemistry Assessment – B. Cropp-Kohlligian, D378920, 10/27/10
Dietary and Drinking Water Exposure Assessment – T. Morton, D384458, 12/01/10
Drinking Water Exposure Assessment – J. Melendez, D428848, 11//8/10
TABLE OF CONTENTS
Page 1 of 38

Page 2 of 38
pg.
1.0
EXECUTIVE SUMMARY .................................................................................................4
2.0 INGREDIENT PROFILE ....................................................................................................7
2.1 Registered Products .............................................................................................................7
2.2
Registered and Proposed New Uses ....................................................................................7
2.3
Structure, Nomenclature and Physical/Chemical Properties ...............................................8
3.0 HAZARD CHARACTERIZATION/ASSESSMENT ........................................................9
3.1 Hazard Characterization .....................................................................................................9
3.2
FQPA Hazard Considerations ...........................................................................................10
3.2.1 Neurotoxicity .......................................................................................................10
3.2.2
Developmental Toxicity  ......................................................................................10
3.2.3 Reproductive Toxicity ..........................................................................................11
3.2.4
Pre-and/or Postnatal Toxicity ................................................................................12
3.2.5    FQPA Factor ..........................................................................................................12
3.3
Toxicity Endpoint Selection ..............................................................................................12
3.3.1    Acute Reference Dose – Females 13- 49...............................................................12
3.3.2
Acute Reference Dose – General Population ........................................................13
3.3.3
Chronic Reference Dose – All Populations ...........................................................13
3.3.4
Classification of Carcinogenic Potential................................................................14
3.4
Recommendation for Aggregate Exposure........................................................................14
3.5
Summary of Endpoints Selected for Risk Assessment......................................................14
3.6 Endocrine Disruption.........................................................................................................15
4.0
DIETARY AND DRINKING WATER EXPOSURE ASSESSMENT ............................16
4.1
Residue Chemistry Profile.................................................................................................16
4.1.1  Metabolism in Primary Crops, Livestock and Rotational Crops...........................16
4.1.2
Residues of Concern ..............................................................................................16
4.1.3
Residue Analytical Method ...................................................................................16
4.1.4
Residues in Crops ..................................................................................................17
4.1.5
Residues in Livestock ............................................................................................17
4.1.6    Residues in Processed Commodities .....................................................................18
4.1.7    Residues in Rotational Crops.................................................................................18
4.1.8 Storage Stability.....................................................................................................18
4.2
Drinking Water Profile ......................................................................................................18
4.2.1
Environmental Fate and Transport ........................................................................18
4.2.2  Estimated Drinking Water Concentrations............................................................19
4.3
Dietary and Drinking Water Exposure and Risk ...............................................................19
4.3.1  Acute Dietary and Drinking Water Analysis.........................................................19
4.3.2  Chronic Dietary and Drinking Water Analysis......................................................20
5.0
AGGREGATE EXPOSURE AND RISK ASSESSMENT ...............................................20

Page 3 of 38
6.0 CUMULATIVE RISK.......................................................................................................21
7.0 DATA NEEDS...................................................................................................................22
7.1 Toxicity Data .....................................................................................................................22
APPENDICES
A. GUIDELINE TOXICOLOGY DATA SUMMARY .........................................................23
A.1
Guideline Data Requirements................................................................................23
A.2
Toxicity Profiles ....................................................................................................24
B. STUDIES REVIEWED FOR ETHICAL CONDUCT ......................................................29
C.
ADDITIONAL TOXICITY STUDIES .............................................................................30
D. METABOLIC PROFILE...................................................................................................34
E. TOXICITY STUDY REFERENCES ................................................................................33

Page 4 of 38
1.0
EXECUTIVE SUMMARY
This assessment provides information to support an amended Section 3 registration for
the use of cyprodinil on pome fruit.  This document addresses the dietary and drinking water
exposure and risk associated with currently registered uses and the proposed new use of
cyprodinil.  It provides a reassessment of tolerances (pesticide residue limits in food) to ensure
that they meet the safety standard established by the Food Quality Protection Act (FQPA) of
1996.
Use Profile
Cyprodinil (4-cyclopropyl-6-methyl-N-phenyl-2-pyrimidinamine) is a systemic anilino-
pyrimidine fungicide.  Permanent tolerances are established (40 CFR §180.532(a)) for residues
of cyprodinil per se in/on a variety of crop commodities, at levels ranging from 0.02 ppm in/on
almonds to 340 ppm in citrus oil.  Cyprodinil is a systemic fungicide and is active through
inhibition of methionine biosynthesis.  Cyprodinil is applied to food crops with aircraft and
ground application equipment.  Cyprodinil is used on ornamentals and landscaped areas on golf
courses and around residential, institutional, public, commercial and industrial buildings, parks,
recreational areas and athletic fields.  It is applied to non-food areas with ground-boom and
handheld spray equipment.  Since the label does not limit use to “professional” or certified
applicators, the Agency believes it is possible for residential “handlers” to obtain and to apply
the product.  Residential exposures are limited to residential applicators since cyprodinil is used
on ornamentals but not on turf.
Proposed Amended Uses
In conjunction with this petition, Syngenta Crop Protection, Inc. is requesting an
amended use of their 75% water-dispersible granular (WDG) formulation of cyprodinil,
Vangard™ Fungicide (EPA Reg. No. 100-828), on pome fruit to reduce the preharvest interval
(PHI) from 72- to 0-days; the current maximum use rate of this product on pome fruit (0.23 lb
ai/A/application (1.4 lb ai/A/season)) will remain unchanged.  They are also requesting an
amended use of their emulsion [oil] in water (EW) formulation of cyprodinil/difenoconazole,
Inspire Super
™
Fungicide (EPA Reg. No. 100-1317), on pome fruit to increase the maximum
use rate of cyprodinil from 0.04 lb ai/A/application (0.16 lb ai/A/season of cyprodinil from
Inspire Super™) to 0.20 lb ai/A/application (1.0 lb ai/A/season of cyprodinil from Inspire
Super™) and reduce the PHI from 86- to 14-days.
In addition, the petitioner, Syngenta Crop Protection, Inc. proposes to amend the
tolerance in 40 CFR §180.532 for residues of the fungicide cyprodinil (2-pyrimidinamine, 4-
cyclopropyl-6-methyl-N-phenyl) in or on fruit, pome, group 11 from 0.1 ppm to 1.7 ppm.

Page 5 of 38
Hazard Identification
The toxicology database for cyprodinil is adequate for evaluating and characterizing
toxicity and selecting endpoints for purposes of this risk assessment.
Cyprodinil has low acute toxicity via the oral, dermal, and inhalation routes (Toxicity
Category III). Cyprodinil is mildly irritating to the eyes (Toxicity Category III) and negligibly
irritating to the skin (Toxicity Category IV).  It is a dermal sensitizer.
The major target organs of cyprodinil are the liver in both rats and mice and the kidney in
rats.  Liver effects observed consistently in subchronic and chronic studies in rats and mice
include increased liver weights, increases in serum clinical chemistry parameters associated with
adverse effects on liver function, hepatocyte hypertrophy, and hepatocellular necrosis.  Adverse
kidney effects include tubular lesions and inflamation following subchronic exposure of male
rats.  The hematopoietic system also appeared to be a target of cyprodinil, causing mild anemia
in rats exposed subchronically.  Chronic effects in dogs were limited to decreased body-weight
gain, decreased food consumption and decreased food efficiency.  There was no evidence of
increased susceptibility in the developmental rat or rabbit study following in utero exposure or in
the two-generation reproduction study following pre- or post-natal exposure.  There was no
evidence of neuropathological or other neurological effects in the available subchronic
neurotoxicity study.  The results of a preliminary immunotoxicity study provided no evidence for
immunotoxicity.  There was no evidence of carcinogenic potential in either the rat chronic
toxicity/carcinogenicity or mouse carcinogenicity studies.
An acute neurotoxicity study (870.6200a) is required in accordance with the revised 40
CFR Part 158 Toxicology Data Requirements.  The available preliminary immunotoxicity study
is considered Upgradeable/Guideline.   The registrant needs to either submit the required Natural
Killer cell activity assay or provide justification for why it is not needed.
Dose Response Assessment
Toxicological points of departure (PODs) were selected for dietary and drinking water
exposure scenarios.  A POD for acute dietary exposure was selected for the population subgroup
females 13-49 years old based on a developmental toxicity study in rabbits.  No acute endpoint
was identified for the remaining population subgroups.  The POD for chronic dietary exposure
was selected from a chronic/carcinogenicity feeding study in rats.  An uncertainty factor of 100x
was applied to PODs for both acute and chronic dietary exposure (10x for interspecies
extrapolation, 10x for intraspecies variation).
Exposure/Risk Assessment and Risk Characterization

Page 6 of 38
Risk assessments were conducted for dietary (food and water) based on registered uses
and requests for reduced PHI and increased tolerance for use of cyprodinil on pome fruit.
Conservative acute chronic dietary and drinking water risk assessments for cyprodinil conclude
that dietary and drinking water exposure estimates are below HED’s level of concern for the
general population and all population subgroups.  The proposed uses do not involve residential
exposure and previous assessments of worker exposure to liquid formulations applied at higher
application rates than those proposed show no risks of concern (D362494, M. Dow, 8/4/09).
Therefore new occupational and residential risk assessments are not required for this action.
Aggregate risks from dietary and post-application residential exposures are not of concern.
Use of Human Studies
This risk assessment is limited to dietary and drinking water exposures and does not rely
on data from studies in which adult human subjects were intentionally exposed to a pesticide or
other chemical.
Environmental Justice
Potential areas of environmental justice concerns, to the extent possible, were considered
in this human health risk assessment, in accordance with U.S. Executive Order 12898, "Federal
Actions to Address Environmental Justice in Minority Populations and Low-Income
Populations," http://www.eh.doe.gov/oepa/guidance/justice/eo12898.pdf).
As a part of every pesticide risk assessment, OPP considers a large variety of consumer
subgroups according to well-established procedures.  In line with OPP policy, HED estimates
risks to population subgroups from pesticide exposures that are based on patterns of that
subgroup’s food and water consumption, and activities in and around the home that involve
pesticide use in a residential setting.
Whenever appropriate, non-dietary exposures based on
home use of pesticide products and associated risks for adult applicators and for toddlers, youths,
and adults entering or playing on treated areas postapplication are evaluated.  Further
considerations are currently in development, as OPP has committed resources and expertise to
the development of specialized software and models that consider exposure to bystanders and
farm workers as well as lifestyle and traditional dietary patterns among specific subgroups.
Regulatory Recommendation
Provided the petitioner submits a revised Section F, HED recommends in favor of the
request to amend the registration of Vangard™ Fungicide (EPA Reg. No. 100-828) to reduce the
preharvest interval (PHI) on pome fruit from 72- to 0-days as well as the request to amend the
registration of Inspire Super
™
Fungicide (EPA Reg. No. 100-1317) to increase the maximum use
rate of cyprodinil on pome fruit from 0.04 lb ai/A/application (0.16 lb ai/A/season of cyprodinil
from Inspire Super™) to 0.20 lb ai/A/application (1.0 lb ai/A/season of cyprodinil from Inspire
Super™) and reduce the PHI from 86- to 14-days.  Furthermore, HED recommends increasing
the permanent tolerances for residues of cyprodinil in/on pome fruit from 0.1 ppm to 1.7 ppm

Page 7 of 38
and in apple wet pomace from 0.15 ppm to 4.6 ppm.  Tolerances should be revised, as needed, to
reflect the correct commodity definitions as specified in the Chemistry Summary Document
(D378920, 10/27/10).
Based on the proposed amended uses of cyprodinil on pome fruit, the currently
established 0.02 ppm tolerance levels for meat byproducts of cattle, goats, horses, and sheep are
adequate but the currently established tolerance expression for livestock commodities should be
changed to reflect measurement of both parent and metabolite CGA-304075.  Separate tolerances
should be established under 40 CFR §180.532(a) for residues of cyprodinil and CGA-304075
(free and conjugated), expressed in parent equivalents, on meat byproducts of cattle, goats,
horses, and sheep at 0.02 ppm (LOQ).
2.0
INGREDIENT PROFILE
2.1
Registered Products
There are currently 5 active Section 3 cyprodinil registrations in the OPPIN data base.
Table 1. Registered Cyprodinil Products
Reg #
Name
% ai
Company Name
100-811 Cyprodinil Technical
99
100-828
Vangard WG Fungicide
75
100-953
Switch 62.5 WG
37.5
100-1317 Inspire Super
24.1
100-RGEI Palladium (Fungicide)
37.5
Syngenta Crop Protection, Inc.
2.2
Registered and Proposed New Uses
Cyprodinil is a systemic anilino-pyrimidine fungicide registered to Syngenta Crop
Protection in the United States for use on a wide variety of fruit, nut, herb and vegetable crops
for the control of various plant diseases.  It is formulated as a 75% water-dispersible granule
(WDG), a 62.5% WDG multiple active ingredient (MAI) product containing 37.5% cyprodinil
and 25% fludioxonil, and as a 67.5% oil emulsion in water (EW) MAI containing 24.1% lb/gal
cyprodinil and 8.4% of difenoconazole.  The current application proposes amending existing
registrations for two products.  Use of Vangard™ Fungicide on pome fruit would be amended to
reduce the PHI from 72- to 0-days.  Use of Inspire Super
™
Fungicide on pome fruit would be
amended to increase the maximum use rate of cyprodinil from 0.04 lb ai/A/application (0.16 lb
ai/A/season of cyprodinil from Inspire Super™) to 0.20 lb ai/A/application (1.0 lb ai/A/season of
cyprodinil from Inspire Super™) and reduce the PHI from 86- to 14-days.  In addition, the
petitioner, Syngenta Crop Protection, Inc. proposes to amend the tolerance in 40 CFR §180.532
for residues of the fungicide cyprodinil (2-pyrimidinamine, 4-cyclopropyl-6-methyl-N-phenyl)
in or on fruit, pome, group 11 from 0.1 ppm to 1.7 ppm.  Maximum rates based on a review of
active and proposed labels are provided in Table 2.

Table 2.  Maximum Application Rates for Cyprodinil Existing and Proposed New Uses
Application Site
Max % AI
Max Single AR
Reg No.
root, leafy, and fruiting vegetables, legumes, citrus, pome, and stone
fruits, berries, nuts, herbs.
75
1.3  lb/ai A
canola grown in Canada
62.5
0.33 lb/ai A
100-828
2.3
Structure, Nomenclature, and Physical/Chemical Properties
The nomenclature and physicochemical properties of cyprodinil are provided in Tables 3
and 4.
Table 3. Cyprodinil Nomenclature.
Chemical structure
N
N
CH
3
N
H
Common name
Cyprodinil
Company experimental name
CGA219417
IUPAC name
(4-cyclopropyl-6-methyl -pyrimidin-2-yl)-phenyl-amine
CAS name
2-pyrimidinamine, 4-cyclopropyl-6-methyl-N-phenyl-
CAS registry number
121552-61-2
Molecular weight
225.29
End-use products (EP)
75% water-dispersible granule (WDG) formulation (Vangard™ Fungicide; EPA Reg. No. 100-
828); a multiple active ingredient (MAI) end-use product (Inspire Super
™
Fungicide; EPA
Reg. No. 100-1317) formulated as an emulsion [oil] in water (EW), containing 8.4%
difenoconazole and 24.1% cyprodinil
Table 4. Physicochemical Properties of Technical Grade of Cyprodinil.
Parameter Value Reference
Melting point/range
75.9 C
pH
9.5 at 25 C (1% aqueous dispersion)
Density
1.21 g/cm at 20 C
<s>3</s>
Water solubility (mg/L at 25 C)
16 at pH 7.6, 20 at pH 5, 13 at pH 7, 5 at pH 9
Solvent solubility (g/L at 25 C)
ethanol-160, acetone-610, toluene-460,
n-octanol-160, n-hexane-30
Vapor pressure
3.8 x 10
<s>-6</s>
mm Hg at 25 C
Dissociation constant, pK
a
4.44 at 20 C
Octanol/water partition coefficient,
Log(K
OW
) at 25 C
3.9 at pH 5, 4.0 at pH 7,  4.0 at pH 9
UV/visible absorption spectrum
(molar absorption coefficients for the
absorbance maximum)
29,200 L/mol·cm at 270.8 nm (neutral)
29,200 L/mol·cm at 251.6 nm (acidic)
29,200 L/mol·cm at 316.8 nm (acidic)
28,400 L/mol·cm at 270.8 nm (basic)
DP# 345970, W. Cutchin,
6/4/08
Page 8 of 38

Page 9 of 38
3.0       HAZARD CHARACTERIZATION/ASSESSMENT
3.1
Hazard Characterization
The toxicology database for cyprodinil is adequate for evaluating and characterizing
cyprodinil toxicity and selecting endpoints for purposes of this risk assessment.
Cyprodinil has low acute toxicity via the oral, dermal, and inhalation routes (Toxicity
Category III).  Cyprodinil is mildly irritating to the eyes (Toxicity Category III) and negligibly
irritating to the skin (Toxicity Category IV).  It is a dermal sensitizer.
The major target organs of cyprodinil are the liver and the kidney.  Liver effects were


[Federal Register Volume 76, Number 103 (Friday, May 27, 2011)]
[Notices]
[Page 30946]
[FR Doc No: 2011-13196]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0471]

Adrien E. Aiache: Debarment Order

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) (the Agency) is issuing
an order under the Federal Food, Drug, and Cosmetic Act (the FD&C Act)
debarring Adrien Aiache, M.D. for 5 years from providing services in
any capacity to a person that has an approved or pending drug product
application. FDA bases this order on findings that Dr. Aiache was
convicted of a misdemeanor under Federal law for conduct relating to
the regulation of a drug product under the FD&C Act and that the type
of conduct underlying the conviction undermines the process for the
regulation of drugs. Dr. Aiache was given notice of the proposed
debarment and an opportunity to request a hearing within the timeframe
prescribed by regulation. Dr. Aiache failed to respond. Dr. Aiache's
failure to respond constitutes a waiver of his right to a hearing
concerning this action.

DATES: This order is effective May 27, 2011.

ADDRESSES: Submit applications for termination of debarment to the
Division of Dockets Management (HFA-305), Food and Drug Administration,
5630 Fishers Lane, Room 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Kenny Shade, Office of Regulatory
Affairs (HFC-230), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    Section 306(b)(2)(B)(i)(I) of the FD&C Act (21 U.S.C.
335a(b)(2)(B)(i)(I)) permits FDA to debar an individual if it finds
that the individual has been convicted of a misdemeanor under Federal
law for conduct relating to the regulation of drug products under the
FD&C Act, and if FDA finds that the type of conduct that served as the
basis for the conviction undermines the process for the regulation of
drugs.
    On June 26, 2007, Dr. Aiache pleaded guilty to a misdemeanor
offense of receipt in interstate commerce of a misbranded drug and
delivery thereof in violation of 21 U.S.C. 331(c), 333(a)(1), and
352(f), and the United States District Court for the Central District
of California entered judgment against him.
    FDA's finding that debarment is appropriate is based on the
misdemeanor conviction referenced herein. The factual basis for the
conviction is as follows: Dr. Aiache was a licensed physician with an
office in Beverly Hills, California. In 2003, Dr. Aiache began ordering
an unapproved Botulinum Toxin Type A drug, Tri-toxin, manufactured by
Toxin Research International, Inc. (TRI), instead of the approved
BOTOX/BOTOX Cosmetic. From on or about September 3, 2003, and
continuing to on or about October 25, 2004, Dr. Aiache placed sixteen
orders for a total of thirty-four vials of TRI-toxin which he had
shipped from Tucson, Arizona to California. He then administered the
TRI-toxin to others for the treatment of facial wrinkles. The TRI-toxin
did not come with labeling or directions on how to dilute the product
for injection. The TRI-toxin label stated ``for research purposes
only'' and ``not for human use,'' as did the TRI invoices. Dr. Aiache
admitted in an interview on May 13, 2005, that he had injected the TRI-
toxin into family members, medical staff personnel, personal friends,
and himself.
    As a result of his convictions, on February 2, 2011, FDA sent Dr.
Aiache a notice by certified mail proposing to debar him for 5 years
from providing services in any capacity to a person that has an
approved or pending drug product application. The proposal was based on
a finding, under section 306(b)(2)(B)(i)(I) of the FD&C Act, that Dr.
Aiache was convicted of a misdemeanor under Federal law for conduct
relating to the regulation of drug products under the FD&C Act, and the
conduct that served as a basis for the conviction undermines the
process for the regulation of drugs. The proposal also offered Dr.
Aiache an opportunity to request a hearing, providing him 30 days from
the date of receipt of the letter in which to file the request, and
advised him that failure to request a hearing constituted a waiver of
the opportunity for a hearing and of any contentions concerning this
action. Dr. Aiache failed to respond within the timeframe prescribed by
regulation and has, therefore, waived his opportunity for a hearing and
waived any contentions concerning his debarment (21 CFR part 12).

II. Findings and Order

    Therefore, the Director, Office of Enforcement, Office of
Regulatory Affairs, under Section 306(b)(2)(B)(i)(I) of the FD&C Act
under authority delegated to him (Staff Manual Guide 1410.35), finds
that Adrien E. Aiache has been convicted of a misdemeanor under Federal
law for conduct relating to the regulation of a drug product under the
FD&C Act, and that the type of conduct that served as a basis for the
conviction undermines the process for the regulation of drugs.
    As a result of the foregoing finding, Dr. Aiache is debarred for 5
years from providing services in any capacity to a person with an
approved or pending drug product application under sections 505, 512,
or 802 of the FD&C Act (21 U.S.C. 355, 360b, or 382), or under section
351 of the Public Health Service Act (42 U.S.C. 262), effective (see
DATES), (see sections 306(c)(1)(B), (c)(2)(A)(iii), and 201(dd) of the
FD&C Act (21 U.S.C. 321(dd))). Any person with an approved or pending
drug product application who knowingly employs or retains as a
consultant or contractor, or otherwise uses the services of Dr. Aiache,
in any capacity during Dr. Aiache's debarment, will be subject to civil
money penalties (section 307(a)(6) of the FD&C Act (21 U.S.C.
335b(a)(6))). If Dr. Aiache provides services in any capacity to a
person with an approved or pending drug product application during his
period of debarment he will be subject to civil money penalties
(section 307(a)(7) of the FD&C Act). In addition, FDA will not accept
or review any abbreviated new drug applications submitted by or with
the assistance of Dr. Aiache during his period of debarment (section
306(c)(1)(B) of the FD&C Act (21 U.S.C. 335a(c)(1)(B)).
    Any application by Dr. Aiache for termination of debarment under
section 306(d)(1) of the FD&C Act should be identified with Docket No.
FDA-2010-N-0471 and sent to the Division of Dockets Management (see
ADDRESSES). All such submissions are to be filed in four copies. The
public availability of information in these submissions is governed by
21 CFR 10.20(j).
    Publicly available submissions may be seen in the Division of
Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.

    Dated: May 16, 2011.
Howard Sklamberg,
Director, Office of Enforcement, Office of Regulatory Affairs.
[FR Doc. 2011-13196 Filed 5-26-11; 8:45 am]
BILLING CODE 4160-01-P


[Federal Register Volume 76, Number 49 (Monday, March 14, 2011)]
[Notices]
[Pages 13668-13669]
[FR Doc No: 2011-5668]

-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Occupational Safety and Health Administration

[Docket No. OSHA-2011-0027]

Respiratory Protection Standard; Extension of the Office of
Management and Budget's (OMB) Approval of Information Collection
(Paperwork) Requirements

AGENCY: Occupational Safety and Health Administration (OSHA), Labor.

ACTION: Request for public comments.

-----------------------------------------------------------------------

SUMMARY: OSHA solicits public comments concerning its proposal to
extend OMB approval of the information collection requirements
specified by the Respiratory Protection Standard (29 CFR 1910.134).

DATES: Comments must be submitted (postmarked, sent, or received) by
May 13, 2011.

ADDRESSES: Electronically: You may submit comments and attachments
electronically at http://www.regulations.gov, which is the Federal
eRulemaking Portal. Follow the instructions online for submitting
comments.
    Facsimile: If your comments, including attachments, are not longer
than 10 pages, you may fax them to the OSHA Docket Office at (202) 693-
1648.
    Mail, hand delivery, express mail, messenger, or courier service:
When using this method, you must submit a copy of your comments and
attachments to the OSHA Docket Office, OSHA Docket No. OSHA-2011-0027,
U.S. Department of Labor, Occupational Safety and Health
Administration, Room N-2625, 200 Constitution Avenue, NW., Washington,
DC 20210. Deliveries (hand, express mail, messenger, and courier
service) are accepted during the Department of Labor's and Docket
Office's normal business hours, 8:15 a.m. to 4:45 p.m., e.t.
    Instructions: All submissions must include the Agency name and OSHA
docket number for the Information Collection Request (ICR) (OSHA-2011-
0027). All comments, including any personal information you provide,
are placed in the public docket without change, and may be made
available online at http://www.regulations.gov. For further information
on submitting comments see the ``Public Participation'' heading in the
section of this notice titled SUPPLEMENTARY INFORMATION.
    Docket: To read or download comments or other material in the
docket, go to http://www.regulations.gov or the OSHA Docket Office at
the address above. All documents in the docket (including this Federal
Register notice) are listed in the http://www.regulations.gov index;
however, some information (e.g., copyrighted material) is not publicly
available to read or download through the Web site. All submissions,
including copyrighted material, are available for inspection and
copying at the OSHA Docket Office. You may also contact Todd Owen at
the address below to obtain a copy of the ICR.

FOR FURTHER INFORMATION CONTACT: Todd Owen, Directorate of Standards
and Guidance, OSHA, U.S. Department of Labor, Room N-3609, 200
Constitution Avenue, NW., Washington, DC 20210; telephone (202) 693-
2222.

SUPPLEMENTARY INFORMATION:

I. Background

    The Department of Labor, as part of its continuing effort to reduce
paperwork and respondent (i.e., employer) burden, conducts a
preclearance consultation program to provide the public with an
opportunity to comment on proposed and continuing information
collection requirements in accordance with the Paperwork Reduction Act
of 1995 (PRA-95) (44 U.S.C. 3506(c)(2)(A)). This program ensures that
information is in the desired format, reporting burden (time and costs)
is minimal, collection instruments are clearly understood, and OSHA's
estimate of the information collection burden is accurate. The
Occupational Safety and Health Act of 1970 (the OSH Act) (29 U.S.C. 651
et seq.) authorizes information collection by employers as necessary or
appropriate for enforcement of the Act or for developing information
regarding the causes and prevention of occupational injuries,
illnesses, and accidents (29 U.S.C. 657). The OSH Act also requires
that OSHA obtain such information with minimum burden upon employers,
especially those operating small businesses, and to reduce to the
maximum extent feasible unnecessary duplication of efforts in obtaining
information (29 U.S.C. 657).
    The Respiratory Protection Standard (29 CFR 1910.134; hereafter,
``the

Standard'') contains information collection requirements that require
employers to: Develop a written respirator program; conduct worker
medical evaluations and provide follow-up medical evaluations to
determine the worker's ability to use a respirator; provide the
physician or other licensed healthcare professional with information
about the worker's respirator and the conditions under which the worker
will use the respirator; and administer fit tests for workers who will
use negative- or positive-pressure, tight-fitting facepieces. In
addition, employers must ensure that workers store emergency-use
respirators in compartments clearly marked as containing emergency-use
respirators. For respirators maintained for emergency use, employers
must label or tag the respirator with a certificate stating the date of
the inspection, the name of the individual who made the inspection, the
findings of the inspection, required remedial action, and the identity
of the respirator.
    The Standard also requires employers to ensure that cylinders used
to supply breathing air to respirators have a certificate of analysis
from the supplier stating that the breathing air meets the requirements
for Type 1--Grade D breathing air; such certification assures employers
that the purchased breathing air is safe. Compressors used to supply
breathing air to respirators must have a tag containing the most recent
change date and the signature of the individual authorized by the
employer to perform the change. Employers must maintain this tag at the
compressor. These tags provide assurance that the compressors are
functioning properly.

II. Special Issues for Comment

    OSHA has a particular interest in comments on the following issues:
     Whether the proposed information collection requirements
are necessary for the proper performance of the Agency's functions,
including whether the information is useful;
     The accuracy of OSHA's estimate of the burden (time and
costs) of the information collection requirements, including the
validity of the methodology and assumptions used;
     The quality, utility, and clarity of the information
collected; and
     Ways to minimize the burden on employers who must comply;
for example, by using automated or other technological information
collection and transmission techniques.

III. Proposed Actions

    OSHA is requesting that OMB extend its approval of the information
collection requirements contained in the Respiratory Protection
Standard (29 CFR 1910.134). The Agency is requesting an increase in
burden hours from 7,159,601 to 7,422,346 (a total increase of 262,745
hours). The Agency will summarize the comments submitted in response to
this notice and will include this summary in the request to OMB.
    Type of Review: Extension of a currently approved collection.
    Title: Respiratory Protection Standard (29 CFR 1910.134).
    OMB Number: 1218-0099.
    Affected Public: Business or other for-profits; Not-for-profit
institutions; Federal government; State, local, or tribal governments.
    Number of Respondents: 618,804.
    Frequency of Response: Annually; monthly; on occasion.
    Total Responses: 23,579,085.
    Average Time per Response: Varies from 5 minutes (.08 hour) to mark
a storage compartment or protective cover to 8 hours for large
employers to gather and prepare information to develop a written plan.
    Estimated Total Burden Hours: 7,422,346.
    Estimated Cost (Operation and Maintenance): $204,136,769.

IV. Public Participation--Submission of Comments on This Notice and
Internet Access to Comments and Submissions

    You may submit comments in response to this document as follows:
(1) Electronically at http://www.regulations.gov, which is the Federal
eRulemaking Portal; (2) by facsimile (fax); or (3) by hard copy. All
comments, attachments, and other material must identify the Agency name
and the OSHA docket number for the ICR (Docket No. OSHA-2011-0027). You
may supplement electronic submissions by uploading document files
electronically. If you wish to mail additional materials in reference
to an electronic or facsimile submission, you must submit them to the
OSHA Docket Office (see the section of this notice titled ADDRESSES).
The additional materials must clearly identify your electronic comments
by your name, date, and the docket number so the Agency can attach them
to your comments.
    Because of security procedures, the use of regular mail may cause a
significant delay in the receipt of comments. For information about
security procedures concerning the delivery of materials by hand,
express delivery, messenger, or courier service, please contact the
OSHA Docket Office at<PHONE_NUMBER>, (TTY<PHONE_NUMBER>).
    Comments and submissions are posted without change at http://www.regulations.gov. Therefore, OSHA cautions commenters about
submitting personal information such as social security numbers and
date of birth. Although all submissions are listed in the http://www.regulations.gov index, some information (e.g., copyrighted
material) is not publicly available to read or download through this
Web site. All submissions, including copyrighted material, are
available for inspection and copying at the OSHA Docket Office.
Information on using the http://www.regulations.gov Web site to submit
comments and access the docket is available at the Web site's ``User
Tips'' link. Contact the OSHA Docket Office for information about
materials not available through the Web site, and for assistance in
using the Internet to locate docket submissions.

V. Authority and Signature

    David Michaels, PhD, MPH, Assistant Secretary of Labor for
Occupational Safety and Health, directed the preparation of this
notice. The authority for this notice is the Paperwork Reduction Act of
1995 (44 U.S.C. 3506 et seq.) and Secretary of Labor's Order No. 4-2010
(75 FR 55355).

    Signed at Washington, DC, on March 9, 2011.
David Michaels,
Assistant Secretary of Labor for Occupational Safety and Health.
[FR Doc. 2011-5668 Filed 3-11-11; 8:45 am]
BILLING CODE 4510-26-P


[Federal Register Volume 87, Number 144 (Thursday, July 28, 2022)]
[Notices]
[Pages 45309-45310]
[FR Doc No: 2022-16180]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #1

    Take notice that the Commission received the following electric
corporate filings:

    Docket Numbers: EC22-93-000.
    Applicants: Lockhart Solar PV, LLC, Lockhart Solar PV II, LLC,
Lockhart Transmission Holdings, LLC, Luz Solar Partners Ltd., VIII, Luz
Solar Partners Ltd., IX.
    Description: Joint Application for Authorization Under Section 203
of the Federal Power Act of Lockhart Solar PV, LLC, et al.
    Filed Date: 7/21/22.
    Accession Number: 20220721-5146.
    Comment Date: 5 p.m. ET 8/11/22.

    Docket Numbers: EC22-94-000.
    Applicants: Midland Cogeneration Venture Limited Partnership, MCV
Partners LLC.
    Description: Application for Authorization Under Section 203 of the
Federal Power Act of Midland Cogeneration Venture Limited Partnership
and MCV Partners LLC.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5031.
    Comment Date: 5 p.m. ET 8/12/22.

    Take notice that the Commission received the following exempt
wholesale generator filings:

    Docket Numbers: EG22-180-000.
    Applicants: Lockhart Solar PV, LLC.
    Description: Notice of Self-Certification of Exempt Wholesale
Generator Status of Lockhart Solar PV, LLC.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5083.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: EG22-181-000.
    Applicants: Lockhart Reserve, LLC.
    Description: Notice of Self-Certification of Exempt Wholesale
Generator Status of Lockhart Reserve, LLC.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5084.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: EG22-182-000.
    Applicants: Lockhart Solar PV II, LLC.
    Description: Notice of Self-Certification of Exempt Wholesale
Generator Status of Lockhart Solar PV II, LLC.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5092.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: EG22-183-000.
    Applicants: Lockhart Transmission Holdings, LLC.
    Description: Notice of Self-Certification of Exempt Wholesale
Generator Status of Lockhart Transmission Holdings, LLC.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5095.
    Comment Date: 5 p.m. ET 8/12/22.

    Take notice that the Commission received the following Complaints
and Compliance filings in EL Dockets:

    Docket Numbers: EL22-75-000.
    Applicants: Nebraska Public Power District.
    Description: Request of the Nebraska Public Power District For
Remedial Relief under Federal Power Act Section 309.
    Filed Date: 6/29/22.
    Accession Number: 20220629-5200.
    Comment Date: 5 p.m. ET 8/12/22.

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER22-1982-000.
    Applicants: Great Prairie Wind, LLC.
    Description: Amendment to May 27, 2022 Market-Based Rate
Application by Great Prairie Wind, LLC.
    Filed Date: 7/21/22.

    Accession Number: 20220721-5149.
    Comment Date: 5 p.m. ET 8/11/22.

    Docket Numbers: ER22-2053-001.
    Applicants: Public Service Company of Colorado.
    Description: Tariff Amendment: 2022-07-22-PSCo-HLYCRS-Const Agrmt-
Parachute-634-1.0.0 to be effective 6/9/2022.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5114.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: ER22-2457-000.
    Applicants: Midcontinent Independent System Operator, Inc., Ameren
Illinois Company.
    Description: Sec.  205(d) Rate Filing: Midcontinent Independent
System Operator, Inc. submits tariff filing per 35.13(a)(2)(iii: 2022-
07-22_SA 2921 Ameren Illinois-Prairie Power 1st Rev T-TIA to be
effective 7/22/2022.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5012.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: ER22-2458-000.
    Applicants: Southern California Edison Company.
    Description: Tariff Amendment: Amended LGIA High 5 Solar--High
Desert Power Project, LLC and HDSI, LLC, SA 229 to be effective 9/21/
2022.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5036.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: ER22-2459-000.
    Applicants: Southern California Edison Company.
    Description: Tariff Amendment: Crimson Second Amend LGIA &
Terminate eTariff record to be effective 9/21/2022.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5067.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: ER22-2460-000.
    Applicants: New York Independent System Operator, Inc.
    Description: Sec.  205(d) Rate Filing: 205 filing of proposed
tariff revisions Demand Side Response for CESIL to be effective 11/1/
2022.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5077.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: ER22-2461-000.
    Applicants: Lockhart Transmission Holdings, LLC.
    Description: Baseline eTariff Filing: Facilities Use Agreements to
be effective 9/19/2022.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5085.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: ER22-2462-000.
    Applicants: Alabama Power Company, Georgia Power Company,
Mississippi Power Company.
    Description: Compliance filing: Alabama Power Company submits
tariff filing per 35: Compliance Filing in Response to Show Cause Order
to be effective 7/23/2022.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5093.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: ER22-2464-000.
    Applicants: Black Hills Power, Inc.
    Description: Sec.  205(d) Rate Filing: Filing of Jurisdictional
Agreements--Misc. Serv. Agreements and Rate Schedules to be effective
12/31/9998.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5101.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: ER22-2465-000.
    Applicants: Black Hills Power, Inc.
    Description: Sec.  205(d) Rate Filing: Filing of Jurisdictional
Agreements--Misc. Serv. Agreements and Rate Schedules to be effective
12/31/9998.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5106.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: ER22-2466-000.
    Applicants: Cube Yadkin Transmission LLC.
    Description: Compliance filing: Order No. 881 Compliance Filing to
be effective 7/12/2025.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5115.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: ER22-2467-000.
    Applicants: ISO New England Inc., Eversource Energy Service Company
(as agent), New England Power Company, Vermont Electric Power Company,
Inc.
    Description: Compliance filing: ISO New England Inc. submits tariff
filing per 35: Amendments to HVDC Transmission Operating Agreement in
Compliance with Order 881 to be effective 9/20/2022.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5124.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: ER22-2468-000.
    Applicants: ISO New England Inc., New England Power Company,
Vermont Electric Power Company, Inc., Eversource Energy Service Company
(as agent).
    Description: Compliance filing: ISO New England Inc. submits tariff
filing per 35: Amendments to the Schedule 20A-Common--Attach M in
Compliance with Order 881 to be effective 9/20/2022.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5127.
    Comment Date: 5 p.m. ET 8/12/22.

    Docket Numbers: ER22-2469-000.
    Applicants: Essential Power Newington, LLC.
    Description: Sec.  205(d) Rate Filing: IROL-CIP Rate Schedule
Filing to be effective 9/21/2022.
    Filed Date: 7/22/22.
    Accession Number: 20220722-5130.
    Comment Date: 5 p.m. ET 8/12/22.

    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: July 22, 2022.
Kimberly D. Bose,
Secretary.
[FR Doc. 2022-16180 Filed 7-27-22; 8:45 am]
BILLING CODE 6717-01-P